+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Unit Dose Manufacturing Market Size, Share Trends Analysis Report By Sourcing (In-house, Outsourcing), By Product (Liquid, Solid), By End-use (Independent Pharmacies, Long Term Care), By Region, And Segment Forecasts, 2025 - 2030- Product Image
Unit Dose Manufacturing Market Size, Share Trends Analysis Report By Sourcing (In-house, Outsourcing), By Product (Liquid, Solid), By End-use (Independent Pharmacies, Long Term Care), By Region, And Segment Forecasts, 2025 - 2030- Product Image
New

Unit Dose Manufacturing Market Size, Share Trends Analysis Report By Sourcing (In-house, Outsourcing), By Product (Liquid, Solid), By End-use (Independent Pharmacies, Long Term Care), By Region, And Segment Forecasts, 2025 - 2030

  • PDF Icon

    Report

  • 110 Pages
  • January 2025
  • Region: Global
  • Grand View Research
  • ID: 5516259
Description Jump to:
The global unit dose manufacturing market size is expected to reach USD 150.61 billion by 2030, registering a CAGR of 11.43% from 2025 to 2030. In the first half of 2020, the growth of the market was stagnant, but the market started to recover by the end of 2020. It was mainly due to the use of unit doses for the treatment of COVID-19 as it decreases the risk involved while handling and pouring doses from the same bottle.

Unit dose manufacturing has many advantages as the drug can be easily identified, and the formulation of the drug is protected until the moment of administration. If the container is intact and the drug has not been used, it can be redisposed and retrieved without changing its formulation. The most important benefit is that it can be administered in the proper dosage and ensures that the patient does not exceed the prescribed limit.

However, the COVID-19 pandemic has a significant effect on the pharmaceutical market. The first half of the COVID-19 pandemic had slowed growth but by the end of 2020, the market started to recover. The unit dose manufacturing is lucratively used in the current scenario as it reduces the risk of handling and contamination. Also, unit doses are widely used in hospitals for COVID-19 patients to safeguard both patients and healthcare personnel to eliminate the possibility of viral transmission by airborne transmission or direct touch.

Unit Dose Manufacturing Market Report Highlights

  • By sourcing, the outsourcing segment led the market with the largest revenue market share of 60.74% in 2024. Outsourcing services dominated the unit dose manufacturing industry, owing to cost-effectiveness, expertise, flexibility, risk reduction, and access to global markets.
  • The solid unit dose segment led the market with the largest revenue share of 50.49% in 2024. Solid unit dosage forms such as tablets and capsules dominate unit dose marketing due to their high demand, widespread applications, and patient convenience.
  • Based on end use, the independent pharmacies segment led the market with the largest revenue share of 39.11% in 2024 and is also anticipated to register at the fastest CAGR over the forecast period.
  • North America dominated the unit dose manufacturing market with the largest revenue share of 37.73% in 2024. The market revenue growth is driven by the region's advanced healthcare infrastructure, high prevalence of chronic diseases, and strong regulatory focus on patient safety and medication accuracy.

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Research Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Regional Scope
1.1.2. Estimates And Forecast Timeline
1.2. Market Definitions
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information Or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.7.2. Parent Market Analysis
1.8. List Of Secondary Sources
1.9. List Of Abbreviations
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Unit Dose Manufacturing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increased Adoption of Unit Doses
3.2.1.2. Benefits of Manufacturing Unit Doses Over Repackaging
3.2.1.3. Growing Outsourcing Activities
3.2.1.4. Technological Advancements in Unit Dose Manufacturing
3.2.1.5. Increasing Prevalence of Chronic Diseases and Demand for Personalized Medicine
3.2.2. Market Restraint Analysis
3.2.2.1. Challenges Associated with the Adoption of Manufactured Unit Doses
3.2.2.2. Compliance Issues with Outsourcing
3.3. Technology Landscape
3.4. Pricing Model Analysis
3.5. Market Analysis Tools
3.5.1. Porter’s Five Forces Analysis
3.5.2. PESTEL Analysis
3.5.3. COVID-19 Impact Analysis
Chapter 4. Unit Dose Manufacturing Market: Sourcing Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Unit Dose Manufacturing Market: Sourcing Movement Analysis
4.3. Unit Dose Manufacturing Market Estimates & Forecasts, by Sourcing, 2018 - 2030 (USD Million)
4.4. In-House
4.4.1. In-House Market Estimates & Forecasts, 2018 - 2030 (USD Million)
4.5. Outsourcing
4.5.1. Outsourcing Market Estimates & Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Unit Dose Manufacturing Market: Product Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Unit Dose Manufacturing Market: Product Movement Analysis
5.3. Unit Dose Manufacturing Market Estimates & Forecasts, by Product, 2018 - 2030 (USD Million)
5.4. Liquid Unit Dose
5.4.1. Liquid Unit Dose Market Estimates & Forecasts, 2018 - 2030 (USD Million)
5.5. Solid Unit Dose
5.5.1. Solid Unit Dose Market Estimates & Forecasts, 2018 - 2030 (USD Million)
5.6. Others
5.6.1. Others Market Estimates & Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Unit Dose Manufacturing Market: End Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Unit Dose Manufacturing Market: End Use Movement Analysis
6.3. Unit Dose Manufacturing Market Estimates & Forecasts, by End Use, 2018 - 2030 (USD Million)
6.4. Independent Pharmacies
6.4.1. Independent Pharmacies Market Estimates & Forecasts, 2018 - 2030 (USD Million)
6.5. Long Term Care Facility
6.5.1. Long Term Care Facility Market Estimates & Forecasts, 2018 - 2030 (USD Million)
6.6. Hospitals
6.6.1. Hospitals Market Estimates & Forecasts, 2018 - 2030 (USD Million)
6.7. Others
6.7.1. Others Market Estimates & Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Unit Dose Manufacturing Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2024 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. North America
7.4.1. Market Estimates and Forecast, (Revenue, USD Million, 2018 - 2030)
7.4.2. U.S.
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. Regulatory Framework
7.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.3. Canada
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Regulatory Framework
7.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.4. Mexico
7.4.4.1. Key Country Dynamics
7.4.4.2. Competitive Scenario
7.4.4.3. Regulatory Framework
7.4.4.4. Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Europe
7.5.1. Market Estimates and Forecast, (Revenue, USD Million, 2018 - 2030)
7.5.2. UK
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Regulatory Framework
7.5.2.4. UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3. Germany
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Regulatory Framework
7.5.3.4. Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.4. France
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Regulatory Framework
7.5.4.4. France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.5. Italy
7.5.5.1. Key Country Dynamics
7.5.5.2. Competitive Scenario
7.5.5.3. Regulatory Framework
7.5.5.4. Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.6. Spain
7.5.6.1. Key Country Dynamics
7.5.6.2. Competitive Scenario
7.5.6.3. Regulatory Framework
7.5.6.4. Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.7. Sweden
7.5.7.1. Key Country Dynamics
7.5.7.2. Competitive Scenario
7.5.7.3. Regulatory Framework
7.5.7.4. Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.8. Denmark
7.5.8.1. Key Country Dynamics
7.5.8.2. Competitive Scenario
7.5.8.3. Regulatory Framework
7.5.8.4. Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.9. Norway
7.5.9.1. Key Country Dynamics
7.5.9.2. Competitive Scenario
7.5.9.3. Regulatory Framework
7.5.9.4. Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Asia Pacific
7.6.1. Market Estimates and Forecast, (Revenue, USD Million, 2018 - 2030)
7.6.2. Japan
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Framework
7.6.2.4. Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.3. China
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Framework
7.6.3.4. China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.4. India
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. Regulatory Framework
7.6.4.4. India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.5. Thailand
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. Regulatory Framework
7.6.5.4. Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.6. South Korea
7.6.6.1. Key Country Dynamics
7.6.6.2. Competitive Scenario
7.6.6.3. Regulatory Framework
7.6.6.4. South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.7. Australia
7.6.7.1. Key Country Dynamics
7.6.7.2. Competitive Scenario
7.6.7.3. Regulatory Framework
7.6.7.4. Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. Latin America
7.7.1. Market Estimates and Forecast, (Revenue, USD Million, 2018 - 2030)
7.7.2. Brazil
7.7.2.1. Key Country Dynamics
7.7.2.2. Competitive Scenario
7.7.2.3. Regulatory Framework
7.7.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7.3. Argentina
7.7.3.1. Key Country Dynamics
7.7.3.2. Competitive Scenario
7.7.3.3. Regulatory Framework
7.7.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8. MEA
7.8.1. Market Estimates and Forecast, (Revenue, USD Million, 2018 - 2030)
7.8.2. South Africa
7.8.2.1. Key Country Dynamics
7.8.2.2. Competitive Scenario
7.8.2.3. Regulatory Framework
7.8.2.4. South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.3. Saudi Arabia
7.8.3.1. Key Country Dynamics
7.8.3.2. Competitive Scenario
7.8.3.3. Regulatory Framework
7.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.4. UAE
7.8.4.1. Key Country Dynamics
7.8.4.2. Competitive Scenario
7.8.4.3. Regulatory Framework
7.8.4.4. UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.5. Kuwait
7.8.5.1. Key Country Dynamics
7.8.5.2. Competitive Scenario
7.8.5.3. Regulatory Framework
7.8.5.4. Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.1.1. Market Leaders
8.1.2. Emerging Players
8.2. Company Market Position Analysis, 2024 (Company Heat Map Analysis)
8.3. Company Profiles
8.3.1. Catalent Inc.
8.3.1.1. Company Overview
8.3.1.2. Financial Performance
8.3.1.3. Service Benchmarking
8.3.1.4. Strategic Initiatives
8.3.2. Unither Pharmaceuticals
8.3.2.1. Company Overview
8.3.2.2. Financial Performance
8.3.2.3. Service Benchmarking
8.3.2.4. Strategic Initiatives
8.3.3. Thermo Fisher Scientific
8.3.3.1. Company Overview
8.3.3.2. Financial Performance
8.3.3.3. Service Benchmarking
8.3.3.4. Strategic Initiatives
8.3.4. Corden Pharma
8.3.4.1. Company Overview
8.3.4.2. Financial Performance
8.3.4.3. Service Benchmarking
8.3.4.4. Strategic Initiatives
8.3.5. Mikart
8.3.5.1. Company Overview
8.3.5.2. Financial Performance
8.3.5.3. Service Benchmarking
8.3.5.4. Strategic Initiatives
8.3.6. Tape Mark
8.3.6.1. Company Overview
8.3.6.2. Financial Performance
8.3.6.3. Service Benchmarking
8.3.6.4. Strategic Initiatives
8.3.7. Renaissance Lakewood LLC
8.3.7.1. Company Overview
8.3.7.2. Financial Performance
8.3.7.3. Service Benchmarking
8.3.7.4. Strategic Initiatives
8.3.8. Medical Packaging Inc
8.3.8.1. Company Overview
8.3.8.2. Financial Performance
8.3.8.3. Service Benchmarking
8.3.8.4. Strategic Initiatives
8.3.9. American Health Packaging
8.3.9.1. Company Overview
8.3.9.2. Financial Performance
8.3.9.3. Service Benchmarking
8.3.9.4. Strategic Initiatives
8.3.10. PCI Pharma Services
8.3.10.1. Company Overview
8.3.10.2. Financial Performance
8.3.10.3. Service Benchmarking
8.3.10.4. Strategic Initiatives
8.3.11. Amcor PLC
8.3.11.1. Company Overview
8.3.11.2. Financial Performance
8.3.11.3. Service Benchmarking
8.3.11.4. Strategic Initiatives
8.3.12. Bristol-Myers Squibb
8.3.12.1. Company Overview
8.3.12.2. Financial Performance
8.3.12.3. Service Benchmarking
8.3.12.4. Strategic Initiatives
8.3.13. AbbVie Inc.
8.3.13.1. Company Overview
8.3.13.2. Financial Performance
8.3.13.3. Service Benchmarking
8.3.13.4. Strategic Initiatives
8.3.14. Merck & Co. Inc.
8.3.14.1. Company Overview
8.3.14.2. Financial Performance
8.3.14.3. Service Benchmarking
8.3.14.4. Strategic Initiatives
8.3.15. Pfizer Inc.
8.3.15.1. Company Overview
8.3.15.2. Financial Performance
8.3.15.3. Service Benchmarking
8.3.15.4. Strategic Initiatives
List of Tables
Table. 1 Market segmentation
Table. 2 Market research process
Table. 3 Information procurement
Table. 4 Primary research pattern
Table. 5 Market research approaches
Table. 6 Value chain-based sizing & forecasting
Table. 7 QFD modelling for market share assessment
Table. 8 Market formulation & validation
Table. 9 Unit dose manufacturing market revenue, 2018 - 2030 (USD Million)
Table. 10 Unit dose manufacturing market snapshot
Table. 11 Unit dose manufacturing market driver impact
Table. 12 Unit dose manufacturing market restraint impact
Table. 13 Unit dose manufacturing sourcing key takeaways (USD Million)
Table. 14 Unit dose manufacturing market: Sourcing movement analysis
Table. 15 In-house market, 2018 - 2030 (USD Million)
Table. 16 Outsourcing market, 2018 - 2030 (USD Million)
Table. 17 Unit dose manufacturing market product key takeaways (USD Million)
Table. 18 Unit dose manufacturing market: Product movement analysis
Table. 19 Liquid unit dose market, 2018 - 2030 (USD Million)
Table. 20 Solid unit dose market, 2018 - 2030 (USD Million)
Table. 21 Others market, 2018 - 2030 (USD Million)
Table. 22 Unit dose manufacturing market end use key takeaways (USD Million)
Table. 23 Unit dose manufacturing market: End use movement analysis
Table. 24 Independent pharmacies market, 2018 - 2030 (USD Million)
Table. 25 Long term care facility market, 2018 - 2030 (USD Million)
Table. 26 Hospitals market, 2018 - 2030 (USD Million)
Table. 27 Others market, 2018 - 2030 (USD Million)
Table. 28 Regional marketplace: Key takeaways
Table. 29 Regional outlook, 2024 & 2030
Table. 30 North America unit dose manufacturing Market, 2018 - 2030 (USD Million)
Table. 31 U.S. unit dose manufacturing market, 2018 - 2030 (USD Million)
Table. 32 Canada unit dose manufacturing market, 2018 - 2030 (USD Million)
Table. 33 Mexico unit dose manufacturing market, 2018 - 2030 (USD Million)
Table. 34 Europe unit dose manufacturing market, 2018 - 2030 (USD Million)
Table. 35 UK unit dose manufacturing market, 2018 - 2030 (USD Million)
Table. 36 Germany unit dose manufacturing market, 2018 - 2030 (USD Million)
Table. 37 France unit dose manufacturing market, 2018 - 2030 (USD Million)
Table. 38 Italy unit dose manufacturing market, 2018 - 2030 (USD Million)
Table. 39 Spain unit dose manufacturing market, 2018 - 2030 (USD Million)
Table. 40 Sweden unit dose manufacturing market, 2018 - 2030 (USD Million)
Table. 41 Denmark unit dose manufacturing market, 2018 - 2030 (USD Million)
Table. 42 Norway unit dose manufacturing market, 2018 - 2030 (USD Million)
Table. 43 Asia Pacific unit dose manufacturing market, 2018 - 2030 (USD Million)
Table. 44 Japan unit dose manufacturing market, 2018 - 2030 (USD Million)
Table. 45 China unit dose manufacturing market, 2018 - 2030 (USD Million)
Table. 46 India unit dose manufacturing market, 2018 - 2030 (USD Million)
Table. 47 Thailand unit dose manufacturing market, 2018 - 2030 (USD Million)
Table. 48 South Korea unit dose manufacturing market, 2018 - 2030 (USD Million)
Table. 49 Australia unit dose manufacturing market, 2018 - 2030 (USD Million)
Table. 50 Latin America unit dose manufacturing market, 2018 - 2030 (USD Million)
Table. 51 Brazil unit dose manufacturing market, 2018 - 2030 (USD Million)
Table. 52 Argentina unit dose manufacturing market, 2018 - 2030 (USD Million)
Table. 53 Middle East & Africa unit dose manufacturing market, 2018 - 2030 (USD Million)
Table. 54 South Africa unit dose manufacturing market, 2018 - 2030 (USD Million)
Table. 55 Saudi Arabia unit dose manufacturing market, 2018 - 2030 (USD Million)
Table. 56 UAE unit dose manufacturing market, 2018 - 2030 (USD Million)
Table. 57 Kuwait unit dose manufacturing market, 2018 - 2030 (USD Million)
Table. 58 Market participant categorization
List of Figures
Fig. 1 List of Tables
Fig. 2 List of Secondary Sources
Fig. 3 List of Abbreviations
Fig. 4 Global Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
Fig. 5 Global Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
Fig. 6 Global Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
Fig. 7 Global Unit Dose Manufacturing, by Region, 2018 - 2030 (USD Million)
Fig. 8 North America Unit Dose Manufacturing, by Country, 2018 - 2030 (USD Million)
Fig. 9 North America Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
Fig. 10 North America Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
Fig. 11 North America Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
Fig. 12 U.S. Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
Fig. 13 U.S. Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
Fig. 14 U.S. Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
Fig. 15 Canada Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
Fig. 16 Canada Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
Fig. 17 Canada Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
Fig. 18 Mexico Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
Fig. 19 Mexico Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
Fig. 20 Mexico Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
Fig. 21 Europe Unit Dose Manufacturing, by Country, 2018 - 2030 (USD Million)
Fig. 22 Europe Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
Fig. 23 Europe Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
Fig. 24 Europe Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
Fig. 25 Germany Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
Fig. 26 Germany Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
Fig. 27 Germany Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
Fig. 28 UK Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
Fig. 29 UK Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
Fig. 30 UK Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
Fig. 31 France Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
Fig. 32 France Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
Fig. 33 France Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
Fig. 34 Italy Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
Fig. 35 Italy Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
Fig. 36 Italy Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
Fig. 37 Spain Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
Fig. 38 Spain Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
Fig. 39 Spain Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
Fig. 40 Denmark Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
Fig. 41 Denmark Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
Fig. 42 Denmark Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
Fig. 43 Sweden Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
Fig. 44 Sweden Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
Fig. 45 Sweden Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
Fig. 46 Norway Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
Fig. 47 Norway Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
Fig. 48 Norway Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
Fig. 49 Asia Pacific Unit Dose Manufacturing, by Country, 2018 - 2030 (USD Million)
Fig. 50 Asia Pacific Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
Fig. 51 Asia Pacific Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
Fig. 52 Asia Pacific Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
Fig. 53 China Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
Fig. 54 China Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
Fig. 55 China Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
Fig. 56 Japan Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
Fig. 57 Japan Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
Fig. 58 Japan Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
Fig. 59 India Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
Fig. 60 India Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
Fig. 61 India Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
Fig. 62 South Korea Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
Fig. 63 South Korea Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
Fig. 64 South Korea Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
Fig. 65 Australia Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
Fig. 66 Australia Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
Fig. 67 Australia Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
Fig. 68 Thailand Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
Fig. 69 Thailand Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
Fig. 70 Thailand Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
Fig. 71 Latin America Unit Dose Manufacturing, by Country, 2018 - 2030 (USD Million)
Fig. 72 Latin America Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
Fig. 73 Latin America Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
Fig. 74 Latin America Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
Fig. 75 Brazil Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
Fig. 76 Brazil Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
Fig. 77 Brazil Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
Fig. 78 Argentina Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
Fig. 79 Argentina Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
Fig. 80 Argentina Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
Fig. 81 Middle East & Africa Unit Dose Manufacturing, by Country, 2018 - 2030 (USD Million)
Fig. 82 Middle East & Africa Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
Fig. 83 Middle East & Africa Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
Fig. 84 Middle East & Africa Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
Fig. 85 South Africa Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
Fig. 86 South Africa Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
Fig. 87 South Africa Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
Fig. 88 Saudi Arabia Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
Fig. 89 Saudi Arabia Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
Fig. 90 Saudi Arabia Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
Fig. 91 UAE Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
Fig. 92 UAE Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
Fig. 93 UAE Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
Fig. 94 Kuwait Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
Fig. 95 Kuwait Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
Fig. 96 Kuwait Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)

Companies Mentioned

  • Catalent Inc.
  • Unither Pharmaceuticals
  • Thermo Fisher Scientific
  • Corden Pharma
  • Mikart LLC
  • LTS LOHMANN Therapie-Systeme AG (TapeMark)
  • Renaissance Lakewood LLC
  • Medical Packaging Inc.
  • American Health Packaging
  • PCI Pharma Services
  • Amcor PLC
  • Bristol-Myers Squibb
  • AbbVie Inc.
  • Amgen
  • West Pharmaceutical Services,
  • Merck & Co. Inc.
  • Pfizer Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages110
PublishedJanuary 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 79.05 Billion
Forecasted Market Value ( USD ) by 2030 $ 150.61 Billion
Compound Annual Growth Rate11.4%
Regions CoveredGlobal
No. of Companies Mentioned17

Related Topics

Related Reports

Unit Dose Manufacturing Market by Product, Sourcing, End-User - Global Forecast 2025-2030 - Product Image

Unit Dose Manufacturing Market by Product, Sourcing, End-User - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Unit Dose Manufacturing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Unit Dose Manufacturing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 180 Pages
  • Global
From
Retail Sourcing and Procurement Market Size, Share & Trends Analysis Report by Component (Solution, Service), Deployment (Cloud, On-premise), Enterprise Size, Region, and Segment Forecasts, 2025-2030 - Product Image

Retail Sourcing and Procurement Market Size, Share & Trends Analysis Report by Component (Solution, Service), Deployment (Cloud, On-premise), Enterprise Size, Region, and Segment Forecasts, 2025-2030

  • Report
  • 100 Pages
  • Global
From
Data Labeling Solution And Services Market Size, Share & Trends Analysis Report By Sourcing Type (In-house, Outsourced), By Type (Text, Image/Video, Audio), By Labeling Type, By Vertical, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Data Labeling Solution And Services Market Size, Share & Trends Analysis Report By Sourcing Type (In-house, Outsourced), By Type (Text, Image/Video, Audio), By Labeling Type, By Vertical, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From
Contract Pharmaceutical Dose Manufacturing Industry: Composition, Size, Market Share and Outlook - 2024 Edition - Product Image

Contract Pharmaceutical Dose Manufacturing Industry: Composition, Size, Market Share and Outlook - 2024 Edition

  • Report
  • 65 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.